StockNews.AISignal intelligence

Signal detail

News insight

Source-backed analysis, the reasoning behind the signal, and its market context.

GLREBearishEarningsShort Term
High materiality9/10

Greenlight Re Announces Financial Results for Second Quarter and Six Months Ended June 30, 2026

StockNews.AIAug 4, 5:27 PM EDT1 source
Trading thesisImportance 9/10

Near-term bearish for GLRE on Q2 miss and BV drop; potential upside if reserve actions and investment results stabilize.

AI summary

What happened and why it matters

Greenlight Capital Re reported Q2 2026 results with a net loss of $29.6 million as catastrophe losses weighed on underwriting, driving the combined ratio to 100.1%. Investment losses amplified the earnings miss, while the company continued a capital-return program with sizable share repurchases. Fully diluted book value per share fell 3.7% to $20.61, signaling near-term pressure even as the six-month BV trend modestly improved.

  • CAT-driven losses pushed the Q2 combined ratio to 100.1%, pressuring profitability.
  • Share buybacks support capital return but BV remains under pressure.
  • BV per share declined 3.7% QoQ to $20.61; six-month BV up 0.9%.
  • Ongoing commentary on macro headwinds and Middle East exposure could influence sentiment.

Sentiment rationale

Q2 earnings miss driven by CAT losses and a large investment loss, leading to a net loss and BV decline. The combination of a 100.1% combined ratio and a 3.7% QoQ BV drop suggests near-term price weakness, despite active buybacks. Market perception will hinge on whether reserves, portfolio performance, and reinsurance rates stabilize in the second half, plus any guidance from the earnings call.

Key facts

  1. 01

    Gross premiums written rose 2% to $183.1M; net premiums earned $161.8M.

  2. 02

    Q2 underwriting produced a $0.2M loss; combined ratio 100.1% due to CAT losses.

  3. 03

    Total investment loss was $23.8M; net loss $29.6M or $0.89 per share.

  4. 04

    Share buybacks: $14.2M in Q2; another $3.9M repurchased by Aug 3 at $16.42.

  5. 05

    Fully diluted BV per share fell 3.7% to $20.61; six-month BV up 0.9%.

Earnings

Earnings. The release presents the quarterly earnings and segment data, including underwriting and investment results, cap‑structure changes, and discussion of reserves and macro risk—typical of an earnings-category report for a specialty reinsurer.